Cheng Dong-Liang, Xiang Yuan-Yuan, Ji Li-juan, Lu Xiao-Jie
Department of Cardiothoracic Surgery, Shiyan Taihe Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, China.
Tumour Biol. 2015 Feb;36(2):479-88. doi: 10.1007/s13277-015-3093-z. Epub 2015 Jan 22.
Competing endogenous RNAs (ceRNAs) refer to RNA transcripts, such as mRNAs, non-coding RNAs, pseudogene transcripts, and circular RNAs, that can regulate each other by competing for the same pool of miRNAs. ceRNAs involve in the pathogenesis of several common cancers such as prostate cancer, liver cancer, breast cancer, lung cancer, gastric cancer, endometrial cancer, and so on. ceRNA activity is determined by factors such as miRNA/ceRNA abundance, ceRNAs binding affinity to miRNAs, RNA editing, and RNA-binding proteins. The alteration of any of these factors may lead to ceRNA network imbalance and thus contribute to cancer initiation and progression. There are generally three steps in ceRNA research conductions: ceRNA prediction, ceRNA validation, and ceRNA functional investigation. Deciphering ceRNA interplay in cancer provides new insight into cancer pathogenesis and opportunities for therapy exploration. In this review, we try to give readers a concise and reliable illustration on the mechanism, functions, research approaches, and perspective of ceRNA in cancer.
竞争性内源RNA(ceRNA)是指RNA转录本,如信使核糖核酸(mRNA)、非编码RNA、假基因转录本和环状RNA,它们可通过竞争同一组微小RNA(miRNA)来相互调节。ceRNA参与了多种常见癌症的发病机制,如前列腺癌、肝癌、乳腺癌、肺癌、胃癌、子宫内膜癌等。ceRNA活性由miRNA/ceRNA丰度、ceRNA与miRNA的结合亲和力、RNA编辑和RNA结合蛋白等因素决定。这些因素中任何一个发生改变都可能导致ceRNA网络失衡,进而促进癌症的发生和发展。ceRNA研究通常有三个步骤:ceRNA预测、ceRNA验证和ceRNA功能研究。解读癌症中的ceRNA相互作用为癌症发病机制提供了新的见解,并为治疗探索提供了机会。在这篇综述中,我们试图向读者简要而可靠地阐述ceRNA在癌症中的机制、功能、研究方法及前景。